Abdullahi Saminu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Abdullahi Saminu has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Amira M. Heniedy
Egyptian Ministry of Agriculture
1 shared publication- Aroop Mohanty
AIIMS Gorakhpur, India
1 shared publication - Chizaram Onyeaghala
Department of Internal Medicine, University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria
1 shared publication Duaa A. Ahmed
Ain Shams University
1 shared publication- J. Jenifer Florence Mary
Department of Community Medicine, Mahatma Gandhi Medical College and Research Institute, Sri Balaji Vidyapeeth University, Pondicherry, India
1 shared publication - Janet Prameela Dsouza
Department of Medical Surgical Nursing, Manipal College of Nursing, Manipal Academy of Higher Education, Manipal, Karnataka, 576104, India
1 shared publication
Latest Publications
- Open Access
- 25 January 2025
- Published by Evidence Journals in Evidence Public Health
- Vol. 1 (1)
Revolutionizing antiviral therapies: the promise of nucleic acid-based interventions
Nucleic acid therapeutics are emerging as transformative agents in antiviral treatment, leveraging precise genetic interventions to combat viral infections. This mini-review examines key modalities including Antisense Oligonucleotides (ASOs), Small Interfering RNAs (siRNAs), CRISPR-based gene editing, and mRNA vaccines. These approaches utilize cellular mechanisms to inhibit viral replication and offer targeted gene silencing, crucial for addressing rapidly mutating viruses. The review highlights advancements in delivery systems, particularly lipid nanoparticles, and discusses the clinical potential and challenges of these therapies, such as safety concerns related to immune responses and genotoxicity. It also underscores the rapid development and effectiveness of mRNA vaccines demonstrated during the COVID-19 pandemic, reflecting the adaptability and potential of nucleic acid therapies. The review calls for continued innovation and multidisciplinary research to enhance the efficacy, safety, and clinical application of these promising antiviral strategies.
- 25 January 2025
- Published by Evidence Journals in Evidence Public Health
- Vol. 1 (1)
Open AccessRevolutionizing antiviral therapies: the promise of nucleic acid-based interventions
Nucleic acid therapeutics are emerging as transformative agents in antiviral treatment, leveraging precise genetic interventions to combat viral infections. This mini-review examines key modalities including Antisense Oligonucleotides (ASOs), Small Interfering RNAs (siRNAs), CRISPR-based gene editing, and mRNA vaccines. These approaches utilize cellular mechanisms to inhibit viral replication and offer targeted gene silencing, crucial for addressing rapidly mutating viruses. The review highlights advancements in delivery systems, particularly lipid nanoparticles, and discusses the clinical potential and challenges of these therapies, such as safety concerns related to immune responses and genotoxicity. It also underscores the rapid development and effectiveness of mRNA vaccines demonstrated during the COVID-19 pandemic, reflecting the adaptability and potential of nucleic acid therapies. The review calls for continued innovation and multidisciplinary research to enhance the efficacy, safety, and clinical application of these promising antiviral strategies.
- Open Access
- 17 December 2024
- Published by Taylor & Francis in Infection Ecology & Epidemiology
- Vol. 15 (1) , 2441534
Climate change and contagion: the emerging threat of zoonotic diseases in Africa
This article investigates the escalating occurrence of zoonotic diseases in Africa, attributing their spread to climate change and human activities. Africa’s unique combination of biodiversity, reliance on animal husbandry, and swift urbanization heightens its susceptibility. Climate change disrupts ecosystems and animal habitats, intensifying human-wildlife interactions. Urbanization, inadequate sanitation, and insufficient healthcare infrastructure further facilitate disease spread. Climate-induced displacement adds another layer of complexity. Mitigation strategies include improving surveillance systems, fostering early detection via point-of-care diagnostics and digital contact tracing, and investing in vaccines and therapeutics. Our purpose of this is to advocate for sustainable land use, robust community-level public health systems, international cooperation, and resource-sharing. We also emphasize the need for effective vector-control policies, dedicated research funding, and annual awareness, vaccination, and early detection campaigns in endemic regions.
- 17 December 2024
- Published by Taylor & Francis in Infection Ecology & Epidemiology
- Vol. 15 (1) , 2441534
Open AccessClimate change and contagion: the emerging threat of zoonotic diseases in Africa
This article investigates the escalating occurrence of zoonotic diseases in Africa, attributing their spread to climate change and human activities. Africa’s unique combination of biodiversity, reliance on animal husbandry, and swift urbanization heightens its susceptibility. Climate change disrupts ecosystems and animal habitats, intensifying human-wildlife interactions. Urbanization, inadequate sanitation, and insufficient healthcare infrastructure further facilitate disease spread. Climate-induced displacement adds another layer of complexity. Mitigation strategies include improving surveillance systems, fostering early detection via point-of-care diagnostics and digital contact tracing, and investing in vaccines and therapeutics. Our purpose of this is to advocate for sustainable land use, robust community-level public health systems, international cooperation, and resource-sharing. We also emphasize the need for effective vector-control policies, dedicated research funding, and annual awareness, vaccination, and early detection campaigns in endemic regions.